1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Anemia, Hemolytic, Acquired in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huseyinov, A; Ozutemiz, O; Saruc, M; Turkel, N; Tuzcuoglu, I; Yuce, G; Yuceyar, H | 1 |
| Sills, RH | 1 |
| Barr, RD; Kelton, JG; Moore, JC; Murphy, WG; Pai, MK | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anemia, Hemolytic, Acquired
| Article | Year |
|---|---|
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations.
Topics: Anemia, Hemolytic; Blood Coagulation Factors; Blood Platelets; Child; Diagnosis, Differential; Endothelium; Epoprostenol; Factor VIII; Female; Fever; Fibrinolytic Agents; Hemolytic-Uremic Syndrome; Humans; Kidney Diseases; Male; Neurologic Manifestations; Platelet Activating Factor; Purpura; Purpura, Thrombotic Thrombocytopenic; Thromboxane A2 | 1984 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anemia, Hemolytic, Acquired
| Article | Year |
|---|---|
An experimental model of hemolysis-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Anemia, Hemolytic; Animals; Disease Models, Animal; Hemolysis; Lipase; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2003 |
Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
Topics: Anemia, Hemolytic; Blood Coagulation Factors; Female; Humans; Infant, Newborn; Molecular Weight; Platelet Activating Factor; Platelet Count; Purpura, Thrombotic Thrombocytopenic; von Willebrand Factor | 1987 |